95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.14%
Negative revenue growth while AEM stands at 8.40%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.47%
Negative gross profit growth while AEM is at 9.32%. Joel Greenblatt would examine cost competitiveness or demand decline.
-7.96%
Negative EBIT growth while AEM is at 160.52%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-7.96%
Negative operating income growth while AEM is at 160.52%. Joel Greenblatt would press for urgent turnaround measures.
-5.12%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.05%
Share reduction more than 1.5x AEM's 0.48%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.31%
Diluted share count expanding well above AEM's 0.54%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-14.11%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-14.11%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
46.59%
10Y revenue/share CAGR at 75-90% of AEM's 57.79%. Bill Ackman would press for new markets or product lines to narrow the gap.
24.76%
5Y revenue/share CAGR under 50% of AEM's 140.85%. Michael Burry would suspect a significant competitive gap or product weakness.
36.40%
3Y revenue/share CAGR under 50% of AEM's 110.18%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
216.23%
5Y OCF/share CAGR at 50-75% of AEM's 335.92%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
-45.21%
Negative 3Y OCF/share CAGR while AEM stands at 7.83%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
219.86%
3Y net income/share CAGR 50-75% of AEM's 362.11%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
196.05%
10Y equity/share CAGR above 1.5x AEM's 63.12%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
188.63%
5Y equity/share CAGR 1.25-1.5x AEM's 148.94%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
291.55%
3Y equity/share CAGR above 1.5x AEM's 87.76%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.63%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
4.08%
Similar asset growth to AEM's 4.12%. Walter Schloss finds parallel expansions or investment rates.
4.14%
BV/share growth above 1.5x AEM's 2.48%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.33%
We cut SG&A while AEM invests at 4.56%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.